Do You Have Guts to Have Food
Keywords:
Gut Microbes, Nutraceuticals, Phytochemicals
Abstract
Developing countries face problems such as aging populations, inadequate food supply, and unbalanced diets. Different factors lead to a clinical pattern of diseases in various part of the world like racial and hereditary, climate, socio-financial condition, dietary habits and mode of living. The outline of gastrointestinal diseases in India differs remarkably from the western parts of the world because of dietary habits of Indian people. On one hand, the developed countries are fighting with diseases such as obesity, osteoporosis, cancer, diabetes, allergies and dental problems. The Asian countries population are hitching with issues such as intestinal ulcers, skin diseases, vector infections and much more. This varies from region to region also. Some of the diseases which are common in India are rarely seen in western countries and vice-versa. As a result, there is a market for new therapeutic medicine, nutrients production and consumption of these products. The role of these supplements in the daily diet is essential or decisive is still not known clearly due to the implausible literature and current approaches in research fields. The present review focuses on role of neutraceuticles on gut health.References
1. Kechagia, M., Basoulis, D., Konstantopoulou, S., Dimitriadi, D., Gyftopoulou, K., Skarmoutsou, N., Fakiri, E.M., Kechagia, M., Basoulis, D., Konstantopoulou, S., et al. (2013). Health Benefits of Probiotics: A Review, Health Benefits of Probiotics: A Review. International Scholarly Research Notices, International Scholarly Research Notices 2013, 2013, e481651.
2. Glick-Bauer, M., and Yeh, M.-C. (2014). The Health Advantage of a Vegan Diet: Exploring the Gut Microbiota Connection. Nutrients 6, 4822–4838.
3. Zhang, Y.-J., Li, S., Gan, R.-Y., Zhou, T., Xu, D.-P., and Li, H.-B. (2015). Impacts of Gut Bacteria on Human Health and Diseases. Int J Mol Sci 16, 7493–7519.
4. Cencic, A., and Chingwaru, W. (2010). The Role of Functional Foods, Nutraceuticals, and Food Supplements in Intestinal Health. Nutrients 2, 611–625.
5. Mueller, N.T., Bakacs, E., Combellick, J., Grigoryan, Z., and Dominguez-Bello, M.G. (2015). The infant microbiome development: mom matters. Trends Mol Med 21, 109–117.
6. Guaraldi F, Salvatori G. Effect of Breast and Formula Feeding on Gut Microbiota Shaping in Newborns. Frontiers in Cellular and Infection Microbiology. 2012;2:94. doi:10.3389/fcimb.2012.00094.
7. Lam, Y.Y., Ha, C.W.Y., Campbell, C.R., Mitchell, A.J., Dinudom, A., Oscarsson, J., Cook, D.I., Hunt, N.H., Caterson, I.D., Holmes, A.J. (2012). Increased Gut Permeability and Microbiota Change Associate with Mesenteric Fat Inflammation and Metabolic Dysfunction in Diet-Induced Obese Mice. PLoS ONE 7, e34233.
8. Ponnusamy K., Choi J., Kim J., Lee S., Lee C. (2011) Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J Med Microbiol 60: 817–827.
9. Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D.R., Fernandes, G.R., Tap, J., Bruls, T., Batto, J.-M., et al. (2011). Enterotypes of the human gut microbiome. Nature 473, 174–180.
10. Power, S.E.; O’Toole, P.W.; Stanton, C.; Ross, R.P.; Fitzgerald, G.F. (2014). Intestinal microbiota, diet and health. Br. J. Nutr. 111, 387–402.
11. Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S.A., Bewtra, M., Knights, D., Walters, W.A., Knight, R., et al. (2011). Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes. Science 334, 105–108.
12. Ding, T., and Schloss, P.D. (2014). Dynamics and associations of microbial community types across the human body. Nature 509, 357–360.
13. Roskam, A.-J.R., Kunst, A.E., Oyen, H.V., Demarest, S., Klumbiene, J., Regidor, E., Helmert, U., Jusot, F., Dzurova, D., Mackenbach, J.P., et al. (2010a). Comparative appraisal of educational inequalities in overweight and obesity among adults in 19 European countries. Int. J. Epidemiol. 39, 392–404.
13. Roskam, A.-J.R., Kunst, A.E., Oyen, H.V., Demarest, S., Klumbiene, J., Regidor, E., Helmert, U., Jusot, F., Dzurova, D., Mackenbach, J.P., et al. (2010b). Comparative appraisal of educational inequalities in overweight and obesity among adults in 19 European countries. Int. J. Epidemiol. 39, 392–404.
14. Gaffe, R. The Current and Future Regulation of Dietary Supplements, 2010.
14. Kalra, E.K. (2003). Nutraceutical-definition and introduction. AAPS PharmSci 5, 27–28.
15. Mayer, E.A. (2011). Gut feelings: the emerging biology of gut–brain communication. Nat Rev Neurosci. 12(8): 1-30. doi:10.1038/nrn3071
16. Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology. 2009;136:2003–2014.
17. DeFelice SL. FIM Rationale and Proposed Guidelines for the Nutraceutical Research & Education Act - NREA, November 10, 2002. Foundation for Innovation in Medicine. Available at: http://www.fimdefelice.org/archives/arc.researchact.html.
18. Puupponen-Pimiä, R., Aura, A.-M., Oksman-Caldentey, K.-M., Myllärinen, P., Saarela, M., Mattila-Sandholm, T., Poutanen, and K (2002). Development of functional ingredients for gut health. Trends in Food Science & Technology 13, 3–11.
19. Borriello, S.P., Setchell, K.D., Axelson, M., and Lawson, A.M. (1985). Production and metabolism of lignans by the human fecal flora. J. Appl. Bacteriol. 58, 37–43.
20. Hertog, M. G. L., Feskens EJM, Hollman PCH (1993). Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet 342:1007–-1011.
21. Knekt P, Kumpulainen J, Järvinen R, Rissanen H, Heliövaara M, Reunanen A, Hakulinen T, Aromaa A Knekt MP, Kumpulainen J, Järvinen R et al.(2002). Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 76:560–568
22. Middleton E, Kandaswami C, Theoharides TC (2000). The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 52:673–751.
23. Barnes, J., Anderson, L.A., and Phillipson, J.D. (2007). Herbal medicines (London ; Grayslake, IL: Pharmaceutical Press).
24. Adlercreutz, H. (1995). Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 103, 103–112.
25. Hakkinen S.H., Ka¨ Renlampi S.O., Mykka¨ Nen H.M., Heinonen M.I., To¨ Rro¨ Nen A.R. 2000. Ellagic acid content in berries: Influence of domestic processing and storage. European Food Research and Technology, 212: 75–80
26. Mazur WM, Uehara M, Wahala K, Adlercreutz H. Phytoestrogen content of berries and plasma concentration and urinary excretion of enterolactone after a single strawberry-meal in human subjects. Br J Nutrition. 2000; 83:381-387.
27. Vivas, N., Lonvaud-Funel, A. and Glories, Y. (1997) Effect of phenolic acids and anthocyanins on growth, viability and malolactic activity of a lactic acid bacterium. Food Microbiology 14, 291±300.
28. Puupponen-Pimiä, R., Nohynek, L., Meier, C., Kähkönen, M., Heinonen, M., Hopia, A. and Oksman-Caldentey, K.-M. (2001), Antimicrobial properties of phenolic compounds from berries. Journal of Applied Microbiology, 90: 494–507. doi:10.1046/j.1365-2672.2001.01271.x
29. Schmidt, D.R., and Sobota, A.E. (1988). An examination of the anti-adherence activity of cranberry juice on urinary and nonurinary bacterial isolates. Microbios 55, 173–181.
30. Howell, A. B., Vorsa, N., Marderosian, A. D., & Foo, L. Y. (1998). Inhibition of the adherence of P-fimbriated Escherichia coli to uro-epithelial surfaces by proanthycyanidin extracts from cranberries. The New England Journal of Medicine, 339, 1085–1086.
31. Ofek, I., Goldhar, J., and Sharon, N. (1996). Anti-Escherichia coli adhesin activity of cranberry and blueberry juices. Adv. Exp. Med. Biol. 408, 179–183.
32. Rauha JP, Remes S, Heinonen M, Hopia A, Kähkönen M, Kujala T, Pihlaja K, Vuorela H, Vuorela P (2000). Antimicrobial effects of Finnish plant extracts containing flavonoids and other phenolic compounds. Int. J. Food Microbiol., 56: 3-12
33. Bojarska, J.E., Zadernowski, R., and Czaplicki, S. (2011). Ellagic acid content in fruits of selected strawberry cultivars. PUBLISHER UWM 171.
2. Glick-Bauer, M., and Yeh, M.-C. (2014). The Health Advantage of a Vegan Diet: Exploring the Gut Microbiota Connection. Nutrients 6, 4822–4838.
3. Zhang, Y.-J., Li, S., Gan, R.-Y., Zhou, T., Xu, D.-P., and Li, H.-B. (2015). Impacts of Gut Bacteria on Human Health and Diseases. Int J Mol Sci 16, 7493–7519.
4. Cencic, A., and Chingwaru, W. (2010). The Role of Functional Foods, Nutraceuticals, and Food Supplements in Intestinal Health. Nutrients 2, 611–625.
5. Mueller, N.T., Bakacs, E., Combellick, J., Grigoryan, Z., and Dominguez-Bello, M.G. (2015). The infant microbiome development: mom matters. Trends Mol Med 21, 109–117.
6. Guaraldi F, Salvatori G. Effect of Breast and Formula Feeding on Gut Microbiota Shaping in Newborns. Frontiers in Cellular and Infection Microbiology. 2012;2:94. doi:10.3389/fcimb.2012.00094.
7. Lam, Y.Y., Ha, C.W.Y., Campbell, C.R., Mitchell, A.J., Dinudom, A., Oscarsson, J., Cook, D.I., Hunt, N.H., Caterson, I.D., Holmes, A.J. (2012). Increased Gut Permeability and Microbiota Change Associate with Mesenteric Fat Inflammation and Metabolic Dysfunction in Diet-Induced Obese Mice. PLoS ONE 7, e34233.
8. Ponnusamy K., Choi J., Kim J., Lee S., Lee C. (2011) Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J Med Microbiol 60: 817–827.
9. Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D.R., Fernandes, G.R., Tap, J., Bruls, T., Batto, J.-M., et al. (2011). Enterotypes of the human gut microbiome. Nature 473, 174–180.
10. Power, S.E.; O’Toole, P.W.; Stanton, C.; Ross, R.P.; Fitzgerald, G.F. (2014). Intestinal microbiota, diet and health. Br. J. Nutr. 111, 387–402.
11. Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S.A., Bewtra, M., Knights, D., Walters, W.A., Knight, R., et al. (2011). Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes. Science 334, 105–108.
12. Ding, T., and Schloss, P.D. (2014). Dynamics and associations of microbial community types across the human body. Nature 509, 357–360.
13. Roskam, A.-J.R., Kunst, A.E., Oyen, H.V., Demarest, S., Klumbiene, J., Regidor, E., Helmert, U., Jusot, F., Dzurova, D., Mackenbach, J.P., et al. (2010a). Comparative appraisal of educational inequalities in overweight and obesity among adults in 19 European countries. Int. J. Epidemiol. 39, 392–404.
13. Roskam, A.-J.R., Kunst, A.E., Oyen, H.V., Demarest, S., Klumbiene, J., Regidor, E., Helmert, U., Jusot, F., Dzurova, D., Mackenbach, J.P., et al. (2010b). Comparative appraisal of educational inequalities in overweight and obesity among adults in 19 European countries. Int. J. Epidemiol. 39, 392–404.
14. Gaffe, R. The Current and Future Regulation of Dietary Supplements, 2010.
14. Kalra, E.K. (2003). Nutraceutical-definition and introduction. AAPS PharmSci 5, 27–28.
15. Mayer, E.A. (2011). Gut feelings: the emerging biology of gut–brain communication. Nat Rev Neurosci. 12(8): 1-30. doi:10.1038/nrn3071
16. Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology. 2009;136:2003–2014.
17. DeFelice SL. FIM Rationale and Proposed Guidelines for the Nutraceutical Research & Education Act - NREA, November 10, 2002. Foundation for Innovation in Medicine. Available at: http://www.fimdefelice.org/archives/arc.researchact.html.
18. Puupponen-Pimiä, R., Aura, A.-M., Oksman-Caldentey, K.-M., Myllärinen, P., Saarela, M., Mattila-Sandholm, T., Poutanen, and K (2002). Development of functional ingredients for gut health. Trends in Food Science & Technology 13, 3–11.
19. Borriello, S.P., Setchell, K.D., Axelson, M., and Lawson, A.M. (1985). Production and metabolism of lignans by the human fecal flora. J. Appl. Bacteriol. 58, 37–43.
20. Hertog, M. G. L., Feskens EJM, Hollman PCH (1993). Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet 342:1007–-1011.
21. Knekt P, Kumpulainen J, Järvinen R, Rissanen H, Heliövaara M, Reunanen A, Hakulinen T, Aromaa A Knekt MP, Kumpulainen J, Järvinen R et al.(2002). Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 76:560–568
22. Middleton E, Kandaswami C, Theoharides TC (2000). The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 52:673–751.
23. Barnes, J., Anderson, L.A., and Phillipson, J.D. (2007). Herbal medicines (London ; Grayslake, IL: Pharmaceutical Press).
24. Adlercreutz, H. (1995). Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 103, 103–112.
25. Hakkinen S.H., Ka¨ Renlampi S.O., Mykka¨ Nen H.M., Heinonen M.I., To¨ Rro¨ Nen A.R. 2000. Ellagic acid content in berries: Influence of domestic processing and storage. European Food Research and Technology, 212: 75–80
26. Mazur WM, Uehara M, Wahala K, Adlercreutz H. Phytoestrogen content of berries and plasma concentration and urinary excretion of enterolactone after a single strawberry-meal in human subjects. Br J Nutrition. 2000; 83:381-387.
27. Vivas, N., Lonvaud-Funel, A. and Glories, Y. (1997) Effect of phenolic acids and anthocyanins on growth, viability and malolactic activity of a lactic acid bacterium. Food Microbiology 14, 291±300.
28. Puupponen-Pimiä, R., Nohynek, L., Meier, C., Kähkönen, M., Heinonen, M., Hopia, A. and Oksman-Caldentey, K.-M. (2001), Antimicrobial properties of phenolic compounds from berries. Journal of Applied Microbiology, 90: 494–507. doi:10.1046/j.1365-2672.2001.01271.x
29. Schmidt, D.R., and Sobota, A.E. (1988). An examination of the anti-adherence activity of cranberry juice on urinary and nonurinary bacterial isolates. Microbios 55, 173–181.
30. Howell, A. B., Vorsa, N., Marderosian, A. D., & Foo, L. Y. (1998). Inhibition of the adherence of P-fimbriated Escherichia coli to uro-epithelial surfaces by proanthycyanidin extracts from cranberries. The New England Journal of Medicine, 339, 1085–1086.
31. Ofek, I., Goldhar, J., and Sharon, N. (1996). Anti-Escherichia coli adhesin activity of cranberry and blueberry juices. Adv. Exp. Med. Biol. 408, 179–183.
32. Rauha JP, Remes S, Heinonen M, Hopia A, Kähkönen M, Kujala T, Pihlaja K, Vuorela H, Vuorela P (2000). Antimicrobial effects of Finnish plant extracts containing flavonoids and other phenolic compounds. Int. J. Food Microbiol., 56: 3-12
33. Bojarska, J.E., Zadernowski, R., and Czaplicki, S. (2011). Ellagic acid content in fruits of selected strawberry cultivars. PUBLISHER UWM 171.
Published
2016-11-02
Issue
Section
Review Articles
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
